HomeNewsBusinessBudget 2022: Govt likely to set roadmap for railway PSUs merger

Budget 2022: Govt likely to set roadmap for railway PSUs merger

Rail Vikas Nigam is to merge with Indian Railway Construction, RailTel with Indian Railway Catering and Tourism and Braithwaite with Rail India Technical and Economic Services.

December 31, 2021 / 14:07 IST
Story continues below Advertisement
The Railway Board has suggested a timeline for the merger of the six PSUs, the officials who did not wish to be identified said.(Image: ShutterStock)
The Railway Board has suggested a timeline for the merger of the six PSUs, the officials who did not wish to be identified said.(Image: ShutterStock)

The Centre is likely to announce a roadmap for the merger of six public sector undertakings (PSUs) under the Ministry of Railways in Budget 2022-23, starting the process for a radical restructuring of these organisations.

The mergers were recommended by principal economic adviser Sanjeev Sanyal in August 2021 in a report on the rationalisation of government bodies under the railway ministry.

Story continues below Advertisement

Top government officials have told Moneycontrol that Finance Minister Nirmala Sitharaman is likely to announce the path towards the merger of Rail Vikas Nigam Ltd (RVNL) with Indian Railway Construction Ltd (IRCON), RailTel Corporation with Indian Railway Catering and Tourism Corporation (IRCTC) and Braithwaite & Co Ltd with Rail India Technical and Economic Services (RITES) when she presents Budget 2022-23 on February 1.

The Railway Board has suggested a timeline for the merger of the six PSUs, the officials who did not wish to be identified said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show